Visa (V) Offering Possible 17.65% Return Over the Next 6 Calendar Days

Visa's most recent trend suggests a bullish bias. One trading opportunity on Visa is a Bull Put Spread using a strike $190.00 short put and a strike $185.00 long put offers a potential 17.65% return on risk over the next 6 calendar days. Maximum profit would be generated if the Bull Put Spread were to expire worthless, which would occur if the stock were above $190.00 by expiration. The full premium credit of $0.75 would be kept by the premium seller. The risk of $4.25 would be incurred if the stock dropped below the $185.00 long put strike price.

The 5-day moving average is moving up which suggests that the short-term momentum for Visa is bullish and the probability of a rise in share price is higher if the stock starts trending.

The 20-day moving average is moving up which suggests that the medium-term momentum for Visa is bullish.

The RSI indicator is at 72.98 level which suggests that the stock is neither overbought nor oversold at this time.

To learn how to execute such a strategy while accounting for risk and reward in the context of smart portfolio management, and see how to trade live with a successful professional trader, view more here

LATEST NEWS for Visa

These 4 Finance Stocks Helped Dow Win Big in 2019
Thu, 09 Jan 2020 13:39:01 +0000
Dow finance stocks – JPM, GS, V, AXP – are expected to continue witnessing bullish investor sentiments as several favorable factors bode well for earnings growth this year.

US Indexes Regain Some Losses to Close Higher Wednesday
Wed, 08 Jan 2020 21:32:21 +0000
S&P; 500 up 0.49% Continue reading…

Dow Jones Today: Trump’s Iran Comments and Jobs Data Spark Stocks
Wed, 08 Jan 2020 21:17:06 +0000
Equities rebounded Wednesday despite a batch of Iran-related headlines last night after President Trump sounded a clear, decisive tone on dealing with the republic and as private payroll data for December gave investors hope the economy will remain sturdy in 2020.Source: Charts Provided by Finviz * The S&P 500 surged 0.49% * The Dow Jones Industrial Average advanced 0.56% * The Nasdaq Composite tacked on 0.67% * On a day when risk was on, UnitedHealth (NYSE:UNH), often viewed as a defensive name, was the Dow's best-performing name with a gain of 2.09%.On Tuesday evening, Iran launched missile strikes against U.S. military installations in Iraq. Fortunately, no casualties have been reported and there is some speculation that Iran missed on purpose. Still, those attacks, futile as they may have been, earned a stinging rebuke from the White House with President Trump promising swift retaliation for any attacks that cost American lives and new economic sanctions against Iran. As for the Tuesday night attacks, it appears U.S. forces were more than ready. * 7 Stocks to Buy That Trump's Tax Cut Truly Rewarded "Most of Iran's missiles are liquid-fueled, which take longer to get ready for launch and are easier to spot. The actual launch is detected by infrared satellites, which can see the plumes and predict the trajectory," reports CBS News.InvestorPlace – Stock Market News, Stock Advice & Trading TipsIn economic news, the ADP private payroll survey showed the addition of 202,000 private sector jobs last month, easily topping the forecast of 150,000 jobs. The Labor Department releases its December jobs report Friday before the open of U.S. markets with economists expecting the addition of 160,000 roles. Boeing AgainIn late trading, 23 of the 30 Dow stocks were higher, but Boeing (NYSE:BA) wasn't one of them. Earlier today, a Boeing 737 passenger operated by a Ukranian airline crashed, killing the 167 passengers and nine crew members aboard, soon after departing the Iranian capital of Tehran.There is some speculation that this crash was the result of an engine failure, but as the crash occurred in Iranian territory and authorities from that country are in possession of the plane's black boxes, the world may never know the true cause of this unfortunate accident.Compounding Boeing's Wednesday woes, Cowen analyst Cai von Rumohr downgraded the stock to "hold" from "buy" with a new price target of $371, down from $419. Walgreens WoesAs I noted yesterday, Walgreens Boots Alliance (NASDAQ:WBA) was scheduled to report earnings this morning and the company did just that. However, investors may have wished the pharmacy operator kept quiet because the report resulted in a 5.84% decline for the stock, by far the worst performance in the Dow Jones today.Walgreens said it earned $1.37 per share on sales of $34.34 billion, but analyst were expecting earnings of $1.41 a share on revenue of $34.60 billion. Finally, Some Good NewsWe're just a few days into 2020 and Microsoft (NASDAQ:MSFT), one of the Dow's top 2019 performers, hasn't been mentioned here as of yet, but today is a good time to change that. The stock climbed nearly 1.6%, as Morgan Stanley analyst Keith Weiss reiterated an "outperform" rating on the name with big price target boost to $189 from $157."Strong positioning for ramping public cloud adoption, large distribution channels and installed customer base, and improve margins support a path well beyond $1 trillion market cap for Microsoft," Weiss said in a note to clients. Charge It UpVisa (NYSE:V) was also among the top Dow stocks today as MoffettNathanson analyst Lisa Ellis reiterated "buy" ratings on that name and rival Mastercard (NYSE:MA). Her new price target on Visa is $230, implying significant upside to today's close of just over $192. * 10 2019 Winners That Will Be 2020 Losers Interestingly, Dow component American Express (NYSE:AXP) joined the credit card party, posting a Wednesday gain of almost 2%. Bottom Line on the Dow Jones TodayIt's not too late for fun and informative historical trends and anecdotes that could be relevant this year. The S&P 500 notched 150 up days last year, a rare occurrence to be sure. In five previous years of that happening, the benchmark U.S. equity gauge finished higher on an annual basis the following year four times, according to Schaeffer's Investment Research.Hopefully, that trend repeats in 2020.As of this writing, Todd Shriber did not own any of the aforementioned securities. More From InvestorPlace * 2 Toxic Pot Stocks You Should Avoid * 7 Stocks to Buy That Could Double for a Second-Consecutive Year * 7 Stocks to Sell to Start the New Year Fresh * 5 Cheap, High-Yield Dividend Stocks for Investors in 2020 The post Dow Jones Today: Trump's Iran Comments and Jobs Data Spark Stocks appeared first on InvestorPlace.

The Difference Between Bitcoin vs. Bitcoin Cash
Wed, 08 Jan 2020 17:35:36 +0000
We break down the difference between bitcoin and bitcoin cash, and what this difference might mean for the current status of the cryptocurrency and its future.

Buy Mastercard and Visa, Analyst Says. They Are in ‘Rarefied Air’ Among Stocks.
Wed, 08 Jan 2020 17:14:00 +0000
The stocks of the credit card companies are “in rarefied air among investment opportunities,” analyst Lisa said in a Tuesday note to clients. Mastercard stock (ticker: MA) has gained 57% in the last 12 months and Visa (V) has risen 39%, while the is up 27% over the same time period. Ellis reiterated her Buy rating on both stocks and raised her price targets on each.

Related Posts

 

MarketTamer is not an investment advisor and is not registered with the U.S. Securities and Exchange Commission or the Financial Industry Regulatory Authority. Further, owners, employees, agents or representatives of MarketTamer are not acting as investment advisors and might not be registered with the U.S. Securities and Exchange Commission or the Financial Industry Regulatory.


This company makes no representations or warranties concerning the products, practices or procedures of any company or entity mentioned or recommended in this email, and makes no representations or warranties concerning said company or entity’s compliance with applicable laws and regulations, including, but not limited to, regulations promulgated by the SEC or the CFTC. The sender of this email may receive a portion of the proceeds from the sale of any products or services offered by a company or entity mentioned or recommended in this email. The recipient of this email assumes responsibility for conducting its own due diligence on the aforementioned company or entity and assumes full responsibility, and releases the sender from liability, for any purchase or order made from any company or entity mentioned or recommended in this email.


The content on any of MarketTamer websites, products or communication is for educational purposes only. Nothing in its products, services, or communications shall be construed as a solicitation and/or recommendation to buy or sell a security. Trading stocks, options and other securities involves risk. The risk of loss in trading securities can be substantial. The risk involved with trading stocks, options and other securities is not suitable for all investors. Prior to buying or selling an option, an investor must evaluate his/her own personal financial situation and consider all relevant risk factors. See: Characteristics and Risks of Standardized Options. The www.MarketTamer.com educational training program and software services are provided to improve financial understanding.


The information presented in this site is not intended to be used as the sole basis of any investment decisions, nor should it be construed as advice designed to meet the investment needs of any particular investor. Nothing in our research constitutes legal, accounting or tax advice or individually tailored investment advice. Our research is prepared for general circulation and has been prepared without regard to the individual financial circumstances and objectives of persons who receive or obtain access to it. Our research is based on sources that we believe to be reliable. However, we do not make any representation or warranty, expressed or implied, as to the accuracy of our research, the completeness, or correctness or make any guarantee or other promise as to any results that may be obtained from using our research. To the maximum extent permitted by law, neither we, any of our affiliates, nor any other person, shall have any liability whatsoever to any person for any loss or expense, whether direct, indirect, consequential, incidental or otherwise, arising from or relating in any way to any use of or reliance on our research or the information contained therein. Some discussions contain forward looking statements which are based on current expectations and differences can be expected. All of our research, including the estimates, opinions and information contained therein, reflects our judgment as of the publication or other dissemination date of the research and is subject to change without notice. Further, we expressly disclaim any responsibility to update such research. Investing involves substantial risk. Past performance is not a guarantee of future results, and a loss of original capital may occur. No one receiving or accessing our research should make any investment decision without first consulting his or her own personal financial advisor and conducting his or her own research and due diligence, including carefully reviewing any applicable prospectuses, press releases, reports and other public filings of the issuer of any securities being considered. None of the information presented should be construed as an offer to sell or buy any particular security. As always, use your best judgment when investing.